X0306 4 2021-02-01 0 0001454789 CATABASIS PHARMACEUTICALS INC CATB 0001843393 Callori Fred C/O CATABASIS PHARMACEUTICALS, INC. 100 HIGH STREET, FLOOR 28 BOSTON MA 02110 1 0 0 0 Series X Convertible Preferred Stock 2021-02-01 4 A 0 1617 3009.53 A Common Stock 1617000 30920 I By Perceptive Xontogeny Venture Fund, LP Upon stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of common stock, each share of Series X Non-Voting Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations. On February 1, 2021, Issuer completed its private placement pursuant to that certain Stock Purchase Agreement dated January 27, 2021 (the "Private Placement"). In connection with the Private Placement, a limited partnership (the "Fund") in which the Reporting Person has an indirect pecuniary interest purchased shares of Series X Convertible Preferred Stock. The Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of his pecuniary interest therein. Exhibit 24 - Power of Attorney. /s/ Benjamin Harshbarger as attorney-in-fact for Frederick P. Callori 2021-02-03